Notice Number: NOT-NS-19-053
Key Dates
Release Date: April 10, 2019
RFA-NS-19-016
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Nursing Research (NINR)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)
Office of Research on Women’s Health (ORWH)
Purpose
The purpose of this notice is to change the Key Dates in RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)". Specifically, an additional receipt has been added for the August Council round on May 20, 2019 (See changes in bold italics below). Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, applicants are strongly encouraged to submit a letter of intent for this receipt date, to allow IC staff to estimate the potential review workload and plan the review.
Part 1. Overview
Key Dates
Currently Reads:
| Application Due Date(s) | January 9, 2019, March 22, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, February 21, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | April 2019, June 2019, November 2019, March 2020, June 2020, November 2020, March 2021, June 2021 |
| Advisory Council Review | May 2019, August 2019, January 2020, May 2020, August 2020, January 2021, May 2021, August 2021 |
| Earliest Start Date | July 2019, October 2019, March 2020, July 2020, October 2020, March 2021,July 2021, October 2021 |
Modified to Read:
| Application Due Date(s) | January 9, 2019, March 22, 2019, May 20, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, February 21, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | April 2019, June 2019, June 2019, November 2019, March 2020, June 2020, November 2020, March 2021, June 2021 |
| Advisory Council Review | May 2019, August 2019, August 2019, January 2020, May 2020, August 2020, January 2021, May 2021, August 2021 |
| Earliest Start Date | July 2019, October 2019, October 2019, March 2020, July 2020, October 2020, March 2021,July 2021, October 2021 |
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Nick Langhals, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email:[email protected]
and Human Services (HHS)
